PITTSBURGH & LONDON--(BUSINESS WIRE)--Helomics, a privately-held, comprehensive personalised healthcare company (headquartered in Pittsburgh, Pennsylvania) that develops innovative next-generation diagnostics for the oncology field, announced today that it is delighted to be supporting the UK’s Personalised Healthcare Alliance. As a founding contributor to the Alliance, Helomics joins the likes of AstraZeneca, Biogen Idec, Cancer Research UK, Epistem, Horizon Discovery, Myeloma UK and MRC Techn